Icares Medicus Inc
ICARES Medicus, Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of ophthalmic medical devices in Taiwan, the United States, England, Japan, Spain, China, and internationally. The company is also involved in the manufacturing, sales, and service of intraocular lenses (IOLs) and its implantation systems for use in treating cataracts, myopia, hyper… Read more
Market Cap & Net Worth: Icares Medicus Inc (6612)
Icares Medicus Inc (TWO:6612) has a market capitalization of $103.69 Million (NT$3.43 Billion) as of March 18, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #21568 globally and #1189 in its home market, demonstrating a 4.18% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Icares Medicus Inc's stock price NT$72.20 by its total outstanding shares 47514584 (47.51 Million).
Icares Medicus Inc Market Cap History: 2016 to 2026
Icares Medicus Inc's market capitalization history from 2016 to 2026. Data shows growth from $67.84 Million to $103.69 Million (4.37% CAGR).
Icares Medicus Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Icares Medicus Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.21x
Icares Medicus Inc's market cap is 0.21 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
1.73x
Icares Medicus Inc's market cap is 1.73 times its annual earnings
862.31x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $72.69 Million | $266.05 Million | $31.25 Million | 0.27x | 2.33x |
| 2018 | $84.70 Million | $329.28 Million | $70.45 Million | 0.26x | 1.20x |
| 2019 | $122.11 Million | $419.36 Million | $81.02 Million | 0.29x | 1.51x |
| 2020 | $88.13 Million | $362.67 Million | $51.91 Million | 0.24x | 1.70x |
| 2021 | $97.48 Million | $393.92 Million | $58.60 Million | 0.25x | 1.66x |
| 2022 | $115.68 Million | $511.85 Million | $128.91 Million | 0.23x | 0.90x |
| 2023 | $180.95 Million | $605.45 Million | $97.73 Million | 0.30x | 1.85x |
| 2024 | $178.07 Million | $859.79 Million | $103.12 Million | 0.21x | 1.73x |
Competitor Companies of 6612 by Market Capitalization
Companies near Icares Medicus Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Icares Medicus Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $170.40 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #362 globally with a market cap of $61.18 Billion USD ( €59.61 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.90 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.40 Billion | $482.76 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #362 | EssilorLuxottica S. A. | PA:EL | $61.18 Billion | €203.00 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.90 Billion | $161.64 |
Icares Medicus Inc Historical Marketcap From 2016 to 2026
Between 2016 and today, Icares Medicus Inc's market cap moved from $67.84 Million to $ 103.69 Million, with a yearly change of 4.37%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$103.69 Million | -2.30% |
| 2025 | NT$106.13 Million | -40.40% |
| 2024 | NT$178.07 Million | -1.59% |
| 2023 | NT$180.95 Million | +56.41% |
| 2022 | NT$115.68 Million | +18.68% |
| 2021 | NT$97.48 Million | +10.61% |
| 2020 | NT$88.13 Million | -27.83% |
| 2019 | NT$122.11 Million | +44.16% |
| 2018 | NT$84.70 Million | +16.53% |
| 2017 | NT$72.69 Million | +7.14% |
| 2016 | NT$67.84 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Icares Medicus Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $103.69 Million USD |
| MoneyControl | $103.69 Million USD |
| MarketWatch | $103.69 Million USD |
| marketcap.company | $103.69 Million USD |
| Reuters | $103.69 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.